CDC Outlines Plan for Cruise Simulations to Test Covid Safety
(Bloomberg) -- The Centers for Disease Control and Prevention issued its guidelines for simulated cruises, a key step through which vessel owners can prove their safety to the government and get approval to resume profitable voyages in U.S. waters.
According to the CDC's new instructions issued Wednesday, cruise companies should recruit “volunteers simulating the role of passengers” on trial sailings. Participants, who must be at least 18, have to either be fully vaccinated or provide a doctor's note or self-certified statement that they have no high-risk conditions.
The voyages should last two to seven days, and companies need to run at least one such simulation for each ship that they want cleared for the next phase: restricted-head-count sailings with paying customers.
The simulations are a key part of the CDC's plan, but they're not the only one. The companies can skip the trials if they ensure that 95% of passengers and 98% of crew are fully vaccinated. It's possible that many cruise companies will avail themselves of both routes back to the seas.
Some other key elements of the simulation plan:
- The ship operators must submit post-voyage Covid-19 testing specimens for at least 75% of volunteers.
- At some point, each ship must simulate all recreational activities the company plans to offer on paying cruises, such as “casinos, spa services, fitness classes, gymnasiums.”
- No self-guided shore excursions will be permitted during the simulations.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.